Boston Bio Systems Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Audited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Boston Bio Systems Limited (Scrip Code: 531458) has informed BSE that its Board of Directors will meet on Friday, 30 May 2025 at its registered office in Ahmedabad. The main agenda is to consider and approve the Audited Financial Results for the quarter and financial year ended 31 March 2025. Any other incidental business may also be taken up with the Chair's permission. In line with insider trading rules, the trading window for directors, officers and designated employees has already been closed since 1 April 2025 and will reopen 48 hours after the results are declared. No financial numbers or outcomes are disclosed in this filing — it is a routine advance notice under SEBI LODR Regulation 29.
This is a standard procedural filing with no direct impact on the stock. Investors should wait for the actual audited FY25 results post 30 May 2025 to gauge the company's real performance and any fundamental signals.